While the renin-angiotensin system is important for adrenomedullary responses to stress, the involvement of specific angiotensin II (Ang II) receptor subtypes is unclear. We examined gene expression changes of angiotensin II type 1A (AT 1A ) and type 2 (AT 2 ) receptors in rat adrenal medulla in response to immobilization stress (IMO). AT 2 receptor mRNA levels decreased immediately after a single 2-h IMO. Repeated IMO also decreased AT 2 receptor mRNA levels, but the decline was more transient. AT 1A receptor mRNA levels were unaltered with either single or repeated IMO, although binding was increased following repeated IMO. These effects of stress on Ang II receptor expression may alter catecholamine biosynthesis, as tyrosine hydroxylase and dopamine b-hydroxylase mRNA levels in PC12 cells are decreased with Ang II treatment in the presence of ZD7155 (AT 1 receptor antagonist) or with CGP42112 (AT 2 receptor agonist) treatment. Involvement of stress-triggered activation of the hypothalamic-pituitaryadrenocortical or sympathoadrenal axis in AT 2 receptor downregulation was examined. Cultured cells treated with the synthetic glucocorticoid dexamethasone displayed a transcriptionally mediated decrease in AT 2 receptor mRNA levels. However, glucocorticoids are not required for the immediate stress-triggered decrease in AT 2 receptor gene expression, as demonstrated in corticotropin-releasing hormone knockout (Crh KO) mice and hypophysectomized rats, although they can regulate basal gene expression. cAMP and pituitary adenylate cyclase-activating polypeptide also reduced AT 2 receptor gene expression and may mediate this response. Overall, the effects of stress on adrenomedullary AT 1A and AT 2 receptor expression may contribute to allostatic changes, such as regulation of catecholamine biosynthesis.
Introduction
The response of an organism to acute stress is necessary for survival. However, when stress is prolonged or repeated, the response is not only adaptive but also becomes maladaptive. With repeated exposure to stress, there is an increase in allostatic load (McEwen & Seeman 1999 , McEwen 2007 . As a result, stress is a major contributor to the development of cardiovascular disorders and neuropsychiatric illnesses and can also adversely influence the progression of chronic diseases, such as diabetes and cancer (reviewed in McEwen (1998) and Chrousos (2009) ).
The physiological responses to stress involve multiple systems. The activation of the hypothalamic-pituitaryadrenocortical (HPA) axis and the catecholaminergic sympathoneural and sympathoadrenal systems is key neuroendocrine responses to stress (reviewed in Kvetnansky et al. (2009) ). The renin-angiotensin system (RAS), which is known for regulating blood pressure and fluid and electrolyte balance, also plays an important role in the stress response (reviewed in Saavedra et al. (2011) and Saavedra (2012) ). Levels of plasma renin as well as circulating and adrenal angiotensin II (Ang II), the main active component of the RAS, are elevated in response to stress ( Jindra & Kvetnanský 1982 , Yang et al. 1993 . The RAS likely contributes to the development of stress-related cardiovascular disorders (Saavedra et al. 2011) ; however, the underlying mechanisms are still unclear.
Ang II is a potent secretagogue that stimulates adrenomedullary norepinephrine and epinephrine release (Feldberg & Lewis 1964) . Accordingly, nephrectomy or treatment with a nonselective Ang II receptor antagonist nearly abrogates catecholamine release from cat adrenal medulla in response to the stress of insulin-induced hypoglycemia (Bumpus et al. 1980) . Ang II also induces catecholamine biosynthesis by elevating gene expression of the catecholamine biosynthetic enzymes, tyrosine hydroxylase (TH), and phenylethanolamine N-methyltransferase (PNMT) (Stachowiak et al. 1990b) . The results may depend on which Ang II receptor subtype is involved.
Ang II binds with equal affinity to two major sites, the angiotensin II type 1 (AT 1 ) and type 2 (AT 2 ) receptors (reviewed in de Gasparo et al. (2000) ). In rodents, there are two subtypes of AT 1 receptor, the AT 1A and AT 1B receptor, which are pharmacologically indistinguishable but differentially regulated (reviewed in Inagami et al. (1994) ). The AT 1 receptors mediate virtually all the well-known effects of Ang II, including vasoconstrictive, hypertrophic, proliferative, and pro-fibrotic effects. Although the expression of AT 1 receptors in rodent adrenal medulla is very low and limited to only the AT 1A receptor subtype (Leong et al. 2002) , there is substantial evidence for a role of AT 1 receptors in maintaining basal adrenomedullary catecholamine synthesis and in mediating central and adrenomedullary responses to stress , 2007 , Leong et al. 2002 , Jezova et al. 2003 .
AT 2 receptor activation has been proposed to oppose AT 1 receptor-mediated effects and is associated with vasodilation; nitric oxide release; and anti-hypertrophic, anti-proliferative, and anti-fibrotic effects (reviewed in de Gasparo et al. (2000) ). Multiple in vivo studies using genetically altered animals or selective pharmacological agents suggest tissue protective properties of the AT 2 receptor subtype in a number of disease states (reviewed in Jones et al. (2008) ). Unlike the AT 1 receptor, the AT 2 receptor is not very abundant in adult tissues, except for the adrenal gland where it is highly expressed in the zona glomerulosa and medulla (Israel et al. 1995) .
While Ang II elevates TH gene expression in primary cultures of bovine adrenomedullary cells (Stachowiak et al. 1990b ), more recently it was shown that activation of the AT 2 receptor inhibits catecholamine synthesis and TH expression and activity in porcine adrenomedullary chromaffin cells (Takekoshi et al. 2000 (Takekoshi et al. , 2002 . AT 2 receptor gene-deficient mice show elevated adrenomedullary Th and AT 1 receptor mRNA levels, norepinephrine and epinephrine levels, as well as enhanced HPA axis stimulation . This indicates that the AT 1 and AT 2 receptors may play opposite roles in the regulation of the adrenomedullary response to stress and that the expression of one receptor type may influence the expression of the other.
The relative expression of AT 1 and AT 2 receptors is an important modulator of adrenomedullary function. The current study is aimed to better understand the changes in Ang II receptor expression in the adrenal medulla in response to acute and repeated stress. Rats were exposed to immobilization stress (IMO), which is a stress model wherein the response of the adrenomedullary catecholaminergic system to various durations and repetitions of this stressor has been well characterized (Sabban & Kvetnanský 2001 , Liu et al. 2008 . The findings reveal a biphasic response of AT 2 receptor gene expression to stress and provide insight into the mechanisms that trigger these dramatic changes.
Materials and methods

Animals
All animal experiments were performed in accordance with the NIH Guide for the Care and Use of Laboratory Animals (NIH publication no. 85-23, revised 1996) and were approved by the NYMC Institutional Animal Care and Use Committee (rat experiments) or the Ethical Committee of the Institute of Experimental Endocrinology, Slovak Academy of Sciences (mouse experiments).
Male, Sprague Dawley rats (250-320 g) were obtained from Taconic Farms (Germantown, NY, USA). Male, corticotropin-releasing hormone knockout (Crh KO) mice (C57B1/129SV) and WT mice, age 150-180 days, were bred at the Institute of Experimental Endocrinology, as described previously (Kvetnansky et al. 2006) . The Crh KO mouse line was originally a generous gift from Dr Joseph A Majzoub (Harvard Medical School, Department of Endocrinology, Boston, MA, USA). The animals were maintained under controlled conditions (23G2 8C, 12 h light:12 h darkness cycle, lights on from 0600 h) with food and water ad libitum.
Hypophysectomized or sham-operated rats (Taconic Farms) were administered saline or 25 mg/kg per day (1 ml/h) hydrocortisone 21-hemisuccinate, sodium salt crystalline (cortisol; Sigma-Aldrich Corp.) for 7 days via osmotic minipump inserted s.c. in the interscapular area. All hypophysectomized rats received isotonic saline instead of drinking water. Complete removal of the pituitary in hypophysectomized rats was visually confirmed.
Stress
IMO, a strong noninvasive stress model, was performed as described previously (Nankova et al. 1994 , Liu et al. 2008 ) on a metal board by taping the limbs with surgical tape and restricting the motion of the head exactly as originally described by Kvetnansky & Mikulaj (1970) . Rats were subjected to single or repeated IMO. For single IMO (1! IMO), rats were immobilized once for 2 h and subsequently killed either immediately (0 h) or 3 h after termination of the stress. For repeated IMO (6!IMO), rats were immobilized for 2 h daily for 6 consecutive days and killed either immediately (0 h) or 3 h after termination of the stress. To elucidate the effect of the last IMO, one group of rats (the adapted control group) was immobilized for all but the last IMO and killed the next day (5!IMOC24 h). Absolute controls were not exposed to stress. For the hypophysectomy experiment, rats were killed immediately after 1!IMO, performed on the seventh day of saline, or cortisol treatment.
Immobilization of WT and Crh KO mice was performed similarly, with the following modifications. For repeated stress, mice were immobilized for 2 h daily for 7 consecutive days (7!IMO). Consequently, the adapted controls were immobilized for 2 h daily for 6 consecutive days and killed 24 h later (6!IMOC24 h).
In all animal experiments, IMO was performed at the same time of the day (between 0800 h and noon). Following decapitation, the left and right adrenals were dissected. Subsequently, any cortex tissue adhering to the adrenal medulla was carefully removed. It has been estimated that the isolated medulla is O90% pure (Liu et al. 2005) . The left and right adrenal medullae from each individual animal were frozen separately in liquid nitrogen and kept at K80 8C.
Primary cultures of rat adrenal medulla and PC12 cell cultures
Rat adrenal medullae were isolated as described earlier and collected in cold Hank's Balanced Salt Solution (HBSS; Invitrogen). Subsequently, the medullae were incubated with filtered dissociation solution containing 2 . 6 mg/ml collagenase type 1 (Worthington Biochemical Corp., Lakewood, NJ, USA), 0 . 15 mg/ml hyaluronidase type 1-S (Sigma-Aldrich Corp.), 3 mg/ml BSA (Fisher Scientific, Pittsburgh, PA, USA), and 20 U DNase (Ambion, Austin, TX, USA) in a 37 8C water bath for 20 min with periodic resuspension, followed by 20 min of continuous resuspension until the medullary tissue was dissociated. The reaction was stopped with cold HBSS and the digested tissue centrifuged at 2000 g for 3 min at 4 8C. The pellet was resuspended in DMEM (Invitrogen) supplemented with 10% fetal bovine serum (FBS) (Gemini Bio-Products, West Sacramento, CA, USA), 5% horse serum (Gemini Bio-Products), and 50 mg/ml streptomycin with 50 IU/ml penicillin (0 . 5%; Invitrogen).
The cells were plated on collagen-coated 12-well tissue culture plates (BD Biosciences, San Jose, CA, USA) and incubated in a 37 8C humidified incubator with 5% CO 2 for 1 h before additional media were added. The media were replaced after 24 h. Cultures were used for treatment between 3 and 4 days after plating.
Rat adrenomedullary-derived PC12 cells were grown in the media described earlier and maintained at 37 8C in a humidified incubator with 5% CO 2 , with media changed every other day, as described previously (Serova et al. 1997) . Before treatment, cells were plated at about 50% density.
Cell culture treatment
For experiments with dexamethasone, 1 day before treatment, the media were replaced with stripped media containing DMEM supplemented with 10% charcoalstripped FBS (Sigma-Aldrich), dialyzed horse serum (Gemini Bio-Products), and antibiotics. Cells were treated with 1 mM dexamethasone (Sigma-Aldrich), a dose that lies within the ranges typically used in PC12 cells and adrenomedullary primary cultures (Stachowiak et al. 1990a , in 0 . 01% ethanol for 3 . 5-24 h and subsequently harvested for total RNA isolation. To determine the role of transcription, 4 mM actinomycin D (Enzo Life Sciences, Farmingdale, NY, USA), a transcription inhibitor, dissolved in 0 . 04% DMSO was added to the cells immediately before dexamethasone treatment. In some experiments, cells were treated with dexamethasone alone or in combination with 200 mM 8-(4-chlorophenylthio)adenosine 3 0 ,5 0 -cyclic monophosphate sodium salt (CPT-cAMP; SigmaAldrich), a membrane permeable cAMP analog, or with 0 . 01 pM to 1000 nM pituitary adenylate cyclase-activating polypeptide (PACAP) 1-38 (Tocris Bioscience, Minneapolis, MN, USA), dissolved in distilled water. Cells were alternatively treated for 8 h with the AT 2 receptor agonist, CGP42112 (1-1000 nM; Tocris Bioscience), or with 10 nM Ang II (Sigma-Aldrich) following 15 min pretreatment with the AT 1 receptor antagonist, ZD7155 (100 nM; Tocris Bioscience), all dissolved in distilled water. In all experiments, controls were treated with vehicle.
Isolation of RNA and quantification of changes in mRNA levels
Total RNA was isolated using the RNeasy Plus Mini Kit (Qiagen). Total RNA concentration was then quantitated using the NanoDrop 2000 (Thermo Fisher Scientific, Waltham, MA, USA) and reverse transcribed using the RevertAid First-Strand cDNA Synthesis Kit (Thermo Fisher Scientific) using the oligo-dT primer. For quantitative real-time PCR, 2 ml cDNA product was mixed with 12 . 5 ml FastStart Universal SYBR Green Master Rox (Roche) and 1 ml of the following primer pairs: rat or mouse Th, dopamine b-hydroxylase (Dbh), AT 1A receptor, AT 2 receptor, or Gapdh (all purchased from Qiagen), and analyzed on an ABI7900HT Real Time PCR instrument (Applied Biosystems). Data are normalized to Gapdh mRNA levels and expressed as the relative fold change vs control, calculated using the DDC t method. Gapdh mRNA levels were not altered by any of the experimental conditions. In earlier experiments, real-time RT-PCR for Th and Dbh was performed on the LightCycler (Roche) as described previously (Sabban et al. 2010 , Serova et al. 2011 . A standard curve plotted using serial dilutions from 2 ng to 0 . 2 pg cDNA was used for quantification by the Fit Points method. Data are normalized to total RNA.
Autoradiography of Ang II receptor types
Binding experiments were performed as described previously (Nishimura et al. 2000) 
Statistical analysis
All data are expressed as meanGS.E.M., unless otherwise noted, with nZ5-8 per group for animal experiments, nZ4-6 per group for experiments in PC12 cells, and nZ3 per group for experiments in primary cultures. Differences were analyzed by Student's t-test (if only two groups) or ANOVA followed by Bonferroni's post hoc analysis (if more than two groups) using GraphPad Prism 4 Software (GraphPad Software, Inc., La Jolla, CA, USA). A value of P%0 . 05 was considered significant.
Results
Effect of single and repeated immobilization stress on AT 1A and AT 2 receptor expression in the adrenal medulla
The stress-triggered changes in AT 1A and AT 2 receptor mRNA levels in rat adrenal medulla were first examined. Rats were exposed to the strong stress of immobilization once or repeatedly for up to 6 days as shown in Fig. 1A . The changes in mRNA levels were determined immediately and 3 h after the final immobilization, chosen based on optimal times for stress-triggered elevations of Th and Pnmt mRNA levels in the adrenal medulla , Nankova et al. 1994 ). There were no significant changes in AT 1A receptor mRNA levels at any of these time points (Fig. 1B) .
By contrast, gene expression of the AT 2 receptor was profoundly altered by the stress and displayed a biphasic effect. Levels of AT 2 receptor mRNA decreased by about 70% immediately and 90% 3 h after exposure to a single 2 h IMO (Fig. 1C) . In the adapted controls, killed 24 h after the fifth consecutive daily IMO (i.e. on the sixth day), AT 2 receptor mRNA levels were elevated by 65%, compared with unstressed absolute controls. However, exposure of these animals to an additional immobilization (sixth daily IMO) also markedly lowered AT 2 receptor mRNA levels to about 50% of unstressed control levels. Moreover, the reduction was more transient than with the first IMO and did not continue to decline 3 h afterward.
Next, we examined the effects of IMO on AT 1 and AT 2 receptor expression using a radioligand binding assay. Three hours after exposure to 1!IMO, there was no change in AT 1 receptor binding and a tendency toward reduced AT 2 receptor binding (Fig. 2) . However, 3 h after 6!IMO, there was an w50% increase in both AT 1 and AT 2 receptor binding. Figure 1 Time course of AT 1A and AT 2 receptor gene expression changes in the adrenal medulla in response to single and repeated IMO. (A) Rats were exposed to IMO for 2 h once (1!) or daily for 6 consecutive days (6!) and then killed either immediately (IMOC0 h) or 3 h after the final IMO (IMOC3 h). The adapted control group was exposed to 5!IMO, then killed on the sixth day (5!IMOC24 h), representing both the starting point for the sixth IMO and the sustained effects of repeated IMO. Absolute controls were not exposed to stress. AT 1A (B) and AT 2 (C) receptor mRNA levels were determined in the adrenal medulla by real-time RT-PCR, normalized to Gapdh mRNA levels, and expressed relative to unstressed absolute controls, taken as 1. *P!0 . 05, ***P!0 . 001 vs absolute control; ## P!0 . 01, ### P!0 . 001 vs adapted control; aa P!0 . 01 vs indicated groups.
Role of the AT 1 and AT 2 receptors on catecholamine biosynthetic enzyme gene expression in PC12 cells
As our results suggest that IMO is changing the expression or binding of the AT 1A and AT 2 receptors in the adrenal medulla under conditions that are also known to elevate expression of the catecholamine biosynthetic enzymes (reviewed in Sabban & Kvetnanský (2001) ), we examined the relationship between them in adrenomedullary derived PC12 cells. Although the AT 1 receptor is expressed at very low levels in PC12 cells, pretreatment with the AT 1 receptor antagonist ZD7155 led to a significant reduction of Th and Dbh mRNA levels in response to Ang II, likely by way of AT 2 receptor activation (Fig. 3A) . This was further studied with the selective AT 2 receptor agonist CGP42112. Treatment with CGP42112 for 8 h led to a dose-dependent decrease in Th (FZ4 . 01; P!0 . 05) and Dbh (FZ14 . 28; P!0 . 001) mRNA levels (Fig. 3B) .
Mechanism of the stress-triggered modulation of AT 2 receptor gene expression
One of the major responses to stress is the activation of the HPA axis. We speculated that the stress-triggered rise in glucocorticoids may mediate some of the observed changes in AT 2 receptor gene expression. Primary rat adrenomedullary cultures were treated with the synthetic glucocorticoid, dexamethasone. Similar to the response with IMO, Th and Dbh mRNA levels were elevated, as expected (Stachowiak et al. 1990a . AT 1A receptor mRNA levels were unchanged, while there was a precipitous decline in AT 2 receptor mRNA levels (Fig. 4A) .
The time course of changes in Th, Dbh, and AT 2 receptor mRNA levels in response to dexamethasone was determined in PC12 cells (Fig. 4B ). Cells were treated with dexamethasone for various times up to 24 h. Th and Dbh mRNA levels were elevated as previously reported (Stachowiak et al. 1990a ). There was a time-dependent decrease in AT 2 receptor mRNA levels (FZ96 . 29; P!0 . 001) from w80 to 10% of basal levels from 3 . 5 to 24 h with dexamethasone. This response is mediated largely at the transcriptional level, as 8-h treatment with dexamethasone in the presence of 4 mM of the transcription inhibitor, actinomycin D, abolished the decrease in AT 2 receptor mRNA levels (Fig. 4C) .
To further understand the importance of glucocorticoids in vivo, we analyzed the changes in AT 2 receptor mRNA levels in the adrenal medulla of Crh KO mice following single (1!) or repeated (7!) IMO (Fig. 5A) . These mice are Subsequently, Th and Dbh mRNA levels were determined by real-time RT-PCR, normalized to total RNA levels, and expressed as the percentage of control levels (dotted line), taken as 100%.
unable to synthesize CRH and do not display the large elevation in plasma ACTH and corticosterone in response to stress (Muglia et al. 2000 , Kvetnansky et al. 2006 . The reduction in AT 2 receptor mRNA levels in the WT mice in response to single or repeated IMO (Fig. 5B ) was similar to the changes observed in rats (Fig. 1C) . A comparison between the WT and Crh KO mice demonstrated no difference in basal AT 2 receptor mRNA levels in unstressed absolute controls.
Immediately following 1!IMO, AT 2 receptor mRNA levels were decreased by w75% in both the WT and Crh KO mice, indicating that the rise in glucocorticoids is not essential for AT 2 receptor downregulation in the immediate response to acute stress. Similarly, there was a 45-65% decline in AT 2 receptor mRNA levels relative to respective adapted controls immediately after exposure to the seventh IMO in both the WT and the Crh KO mice.
However, in the adapted controls (studied 24 h after the sixth IMO and not exposed to the seventh IMO), AT 2 receptor mRNA levels were elevated by approximately twofold in the Crh KO mice but not significantly in the WT mice, relative to respective genotype-specific unstressed absolute controls. This suggests that the stress-triggered elevation in glucocorticoids may attenuate upregulation of AT 2 receptor gene expression in the prolonged response to repeated stress exposure.
We further analyzed the role of glucocorticoids in the regulation of AT 2 receptor gene expression in hypophysectomized rats under basal conditions and in response to 1!IMO. Compared with sham-operated controls, AT 2 receptor mRNA levels were increased by approximately threefold in hypophysectomized rats (Fig. 6 ). This induction is reversed by cortisol supplementation, indicating that glucocorticoids are potent negative regulators of AT 2 receptor gene expression under basal conditions. Immediately following 1!IMO, however, AT 2 receptor mRNA levels are significantly reduced in both sham-operated and hypophysectomized rats compared with respective unstressed controls. These data provide further evidence that glucocorticoids are not essential for the decrease in AT 2 receptor mRNA levels immediately following IMO.
As the stress-triggered reduction in adrenomedullary AT 2 receptor mRNA levels was observed in Crh KO mice and hypophysectomized rats, a non-HPA mechanism likely mediates this response. Stress-triggered activation of the splanchnic nerve markedly increases nicotinic cholinergic stimulation of the adrenal medulla as well as release of PACAP, which can elevate cAMP levels in chromaffin cells. Therefore, we looked at the response of AT 2 receptor gene expression to combined elevations in both cAMP and glucocorticoids. PC12 cells were treated for 24 h with 200 mM CPT-cAMP, a membrane permeable cAMP analog, alone or together with 1 mM dexamethasone. AT 2 receptor mRNA levels were decreased by approximately three orders of magnitude in response to CPT-cAMP (Fig. 7A) . The combined treatment of CPT-cAMP and dexamethasone lowered AT 2 receptor mRNA levels to a similar extent. The response to PACAP was also examined. Treatment of PC12 cells for 7 h with concentrations of 0 . 01 pM to 1000 nM PACAP 1-38, the predominant endogenous form, elicited a dose-dependent reduction in AT 2 receptor mRNA levels (FZ71 . 13; P!0 . 0001), while elevating Th (FZ26 . 45; P!0 . 0001) and Dbh (FZ130 . 40; P!0 . 0001) mRNA levels (Fig. 7B) . A 90% reduction in AT 2 receptor mRNA levels was observed with 1000 nM PACAP 1-38, the highest concentration tested. These results indicate that PACAP-triggered elevation of cAMP could be mediating downregulation of AT 2 receptor gene expression immediately and shortly after stress.
Discussion
This study showed, for the first time, the kinetics of AT 1A and AT 2 receptor gene expression changes in the adrenal medulla in response to single and repeated exposure to IMO. AT 1A receptor mRNA levels are unaltered by any of the conditions examined, although binding is increased following repeated IMO. By contrast, AT 2 receptor gene expression is especially sensitive to IMO and demonstrated a biphasic response. Immediately following either single or repeated IMO, AT 2 receptor gene expression is rapidly downregulated. However, after 24 h recovery from repeated exposures to the stress, AT 2 receptor gene expression is higher than in unstressed absolute controls (as seen in adapted controls). AT 2 receptor binding is actually elevated 3 h after 6!IMO, similar to the AT 1A receptor. Together, these findings suggest that IMO alters the ratio of AT 1A and AT 2 receptor subtypes, which can affect catecholamine biosynthesis. Indeed, IMO changes the expression or binding of these receptors at a time when expression of the catecholamine biosynthetic enzymes is elevated (reviewed in Sabban & Kvetnanský (2001) ). A role of AT 1 receptors is supported by the finding that Th and Dbh mRNA levels in PC12 cells are decreased by Ang II treatment in the presence of ZD7155 (an AT 1 receptor antagonist). Conversely, treatment with the AT 2 receptor agonist CGP42112 decreased Th and Dbh mRNA levels. Experiments to determine the mechanism by which stress alters AT 2 receptor gene expression show that glucocorticoids are able to lower AT 2 receptor mRNA levels in a transcriptionally mediated pathway. In this regard, glucocorticoids can act as negative regulators of basal adrenomedullary AT 2 receptor gene expression and appear to attenuate the upregulation of AT 2 receptor gene expression in the prolonged response to repeated stress. However, they are not essential for the rapid drop in AT 2 receptor gene expression in the immediate response to stress. Instead, this study suggests a possible role of PACAP and cAMP in the regulation of AT 2 receptor gene expression.
Stress-triggered changes in Ang II receptor expression in the adrenal medulla AT 1 and AT 2 receptor gene and protein expression were studied using real-time RT-PCR and receptor binding, WT and Crh KO mice were exposed to IMO for 2 h once (1!) or daily for 7 consecutive days (7!) and then killed immediately after the final IMO (IMOC0 h). The adapted control group was exposed to 6!IMO, then killed on the seventh day (6!IMOC24 h), representing both the starting point for the seventh IMO and the sustained effects of repeated IMO. Absolute controls were not exposed to stress. (B) AT 2 receptor mRNA levels in the adrenal medulla of WT or Crh KO mice were determined by realtime RT-PCR, normalized to Gapdh mRNA levels, and expressed relative to WT absolute control levels, taken as 1. *P!0 . 05, ***P!0 . 001 vs genotype-matched absolute control; Stress and adrenomedullary AT 2 receptor . R NOSTRAMO and others 297 as the commercially available antibodies for the AT 1 (Benicky et al. 2012) and AT 2 receptors (R Nostramo, E L Sabban, J M Saavedra 2012, unpublished observations) are not specific. The downregulation of AT 2 receptor mRNA levels to as low as 1/10 of basal levels, observed 3 h after 1!IMO, is also reflected by a tendency for reduced AT 2 receptor binding. The decline in AT 2 receptor binding with 1!IMO is less pronounced than the changes in mRNA levels. This is probably due to the time point examined (3 h after the IMO), as the reduction in mRNA levels is likely to precede the changes in protein expression. Conversely, neither AT 1A receptor mRNA levels nor AT 1 receptor binding is altered by 1!IMO. Therefore, acute exposure to IMO may trigger an increase in the relative expression of AT 1A to AT 2 receptors. The changes in Ang II receptor expression following repeated stress exposure are different. With repeated IMO, there is a drop in AT 2 receptor mRNA levels immediately after the stress, yet at the time examined (3 h afterwards) binding is elevated compared with unstressed absolute controls. This could reflect 1) the decrease in AT 2 receptor mRNA levels from a higher starting point before the sixth IMO (adapted controls) than before the first IMO (absolute controls) and 2) the more transient reduction in AT 2 receptor mRNA levels after repeated compared with single IMO. AT 1 receptor binding is also elevated 3 h after 6!IMO, although there is no change in mRNA levels. This could reflect increased receptor stability, decreased recycling, or altered dimerization patterns without alterations in receptor gene transcription.
The changes in adrenomedullary AT 1A and AT 2 receptor mRNA levels were previously examined immediately following exposure of rats to restraint stress using in situ hybridization and ligand binding assays (Leong et al. 2002) . Similar to our results with IMO using quantitative RT-PCR, AT 2 receptor mRNA levels decreased immediately following a single 2-h restraint. In contrast to our finding of a transient decline in AT 2 receptor mRNA levels with repeated (6 daily) IMO, AT 2 receptor mRNA did not differ from basal levels immediately following repeated (7 daily) exposures to restraint stress (Leong et al. 2002) . Additionally, AT 1 receptor binding was unaltered immediately following repeated restraint stress, yet increased 3 h after repeated immobilization stress. These differences may reflect the decreased severity or more rapid habituation to the milder stress of restraint, compared with immobilization.
Effects of stress-triggered modulation of Ang II receptor expression on adrenomedullary function
The altered expression of AT 1 and AT 2 receptors likely has important consequences for the adrenomedullary response to stress, and in particular the degree of catecholamine production and release. Previous data support an inhibitory role of the AT 2 receptor and a stimulatory role of the AT 1 receptor on adrenomedullary catecholamine biosynthesis in response to selective Ang II receptor subtype activation in cultured porcine adrenomedullary chromaffin cells and in mouse adrenal medulla (Takekoshi et al. 2000 . Through the pharmacological application of the compounds CGP42112 and ZD7155, we found that the AT 1 and AT 2 receptors mediate similar converse effects on Th mRNA levels, and for the first time, Dbh mRNA levels in PC12 cells. CGP42112, a partial AT 2 receptor agonist, can displace AT 2 receptors selectively and with high affinity (Heemskerk & Saavedra 1995) . At the higher concentrations used here, however, it may exert additional effects unrelated to AT 2 receptors, as is the case for compound 21 (reviewed in Henrion (2012) ). Similarly, ZD7155, a high-affinity AT 1 receptor antagonist (Remuzzi et al. 1996) , has been used at high concentrations and the results obtained may be in part the consequence of nonselective effects. To completely elucidate the role of AT 2 receptors, it will be necessary to develop novel very specific, potent, and selective receptor agonists and antagonists. As AT 1 receptor expression is very low in PC12 cells (data not shown), the altered response of Th and Dbh gene expression to Ang II in the presence of ZD7155 suggests that small changes in the ratio of AT 1A /AT 2 receptor expression may have significant effects on catecholamine biosynthesis following receptor activation. We hypothesize that the decrease in AT 2 receptor activation in response to acute stress may remove an inhibitory factor in catecholamine production, thus allowing AT 1 receptor stimulation by increased circulating and/or locally produced Ang II to increase catecholamine formation. In this regard, adrenal and urinary norepinephrine and epinephrine levels were decreased following isolation stress in rats treated with the AT 1 receptor antagonist candesartan . Conversely, the increase in AT 2 receptor gene expression following prolonged exposure to stress (observed in adapted controls) may be a protective mechanism, as AT 2 receptor upregulation mediates neuro-, vaso-, and reno-protective effects in numerous pathologies (reviewed in Jones et al. (2008) ).
Role of the HPA and sympathoadrenal axes in the downregulation of AT 2 receptor gene expression in response to stress One of the major responses to stress is the activation of the HPA axis with elevations in plasma ACTH and corticosterone levels. Treatment of rat adrenal medulla primary cultures and PC12 cells with the synthetic glucocorticoid dexamethasone decreases AT 2 receptor mRNA levels. In this regard, dexamethasone decreased AT 2 receptor transcription and mRNA levels in serum-depleted PC12 cells . This response in PC12 cells is progressive and is inhibited by actinomycin D, indicating that it is likely transcriptionally mediated. Accordingly, the promoter of the AT 2 receptor is reported to contain a glucocorticoid regulatory motif (Martin & Elton 1995 , Ichiki et al. 1996 . Our in vivo data demonstrate that glucocorticoids can act as negative regulators of basal adrenomedullary AT 2 receptor gene expression as cortisol supplementation reversed the hypophysectomy-induced increase in AT 2 receptor mRNA levels. However, this effect on basal AT 2 receptor gene expression was not observed in Crh KO mice. This difference may be due to activation of compensatory pathways or strengthening of redundant pathways, the consequences of the life-long Crh KO.
However, in response to stress, AT 2 receptor mRNA levels are decreased in WT and Crh KO mice. While this suggests that the stress-triggered rise in glucocorticoids is not essential for AT 2 receptor downregulation, it does not rule out a role for aldosterone. The absence of CRH has no effect on levels of plasma aldosterone (Muglia et al. 1995) , which is released in response to stress (Stier et al. 2004 ) and can inhibit adrenomedullary AT 2 receptor mRNA levels (Wang et al. 1998) . Conversely, hypophysectomy reduces basal plasma aldosterone levels (Rauschkolb et al. 1956 , Balment et al. 1986 ) and probably aldosterone release during stress. As AT 2 receptor mRNA levels are decreased following acute stress in sham-operated and hypophysectomized rats, the involvement of aldosterone is unlikely.
Even though glucocorticoids do not appear to be required for the downregulation of AT 2 receptor mRNA levels immediately following IMO, the findings suggest that they may attenuate AT 2 receptor gene expression in the prolonged response following repeated exposure to stress. Glucocorticoids may dampen the effects mediated by elevated AT 2 receptor expression in the long-term response to repeated stress exposure.
Much like the absence of an effect of IMO on adrenomedullary AT 1A receptor mRNA levels, dexamethasone also did not change AT 1A receptor gene expression. This suggests that there may be tissue-specific differences in glucocorticoid-mediated regulation of the AT 1A receptor gene as its promoter contains a glucocorticoid response element and dexamethasone treatment increased promoter activity in rat vascular smooth muscle cells (Guo et al. 1995 .
In addition to glucocorticoids, IMO has been shown to activate multiple signaling pathways in the adrenal medulla (reviewed in Kvetnansky et al. (2009) ) as well as lead to the induction of growth factors and cytokines (Liu et al. 2008) , which are also implicated in the downregulation of AT 2 receptor gene expression in PC12 cells . Elevated cAMP, by CPT-cAMP, was found to be very effective in lowering AT 2 receptor mRNA levels in PC12 cells, as previously observed in dibutyryl cAMP-treated serum-depleted PC12 cells, which triggered destabilization of AT 2 receptor mRNA (Murasawa et al. 1996) . After 24 h treatment with CPT-cAMP, there is almost a complete loss (three orders of magnitude decline) of AT 2 receptor mRNA levels, whether in the presence or absence of dexamethasone. Elevated cAMP could be involved in mediating the large reduction in AT 2 receptor gene expression with IMO. Stimulation of the adrenal medulla by release of acetylcholine and PACAP from the splanchnic nerve, with subsequent elevations in calcium and cAMP and their signaling pathways, are important in mediating the adrenomedullary response to stress (Hamelink et al. 2002 , Kvetnansky et al. 2009 , Stroth & Eiden 2010 . Our results show that PACAP decreases AT 2 receptor mRNA levels in PC12 cells and thus may mediate the observed stress-induced changes in AT 2 receptor gene expression.
Overall, the changes in AT 1 and AT 2 receptor expression in the adrenal medulla likely contribute to the regulation of adrenomedullary function in response to stress. The rapid decrease in AT 2 receptor expression observed immediately following a single exposure to stress would result in increased AT 1 receptor activation, increasing catecholamine biosynthesis, and release to handle the immediate threat to homeostasis. Conversely, upregulation of the AT 2 receptor may serve a protective function after prolonged repeated stress exposure.
